Analysis of Tubulysin Biosynthetic Genes in Archangium gephyra
1
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Tubulysins are a group of bioactive secondary metabolites from myxobacteria exhibiting strong anticancer activity against various cancer cell lines. In this study, we describe the identification of putative tubulysin biosynthetic gene clusters (tubA~tubF) in the genome sequences of two tubulysin-producing myxobacterial strains, Archangium gephyra MEHO_002 and MEHO_004. The inactivation of the putative tubulysin biosynthetic genes resulted in a tubulysin-production defect. The DNA sequences of the A. gephyra MEHO_002 and MEHO_004 tubulysin biosynthetic genes were 97% identical, and the amino acid sequences of the encoded proteins shared a similarity of 97−100%. The nucleotide sequences of the tubulysin biosynthetic gene clusters in MEHO_002 and MEHO_004 were 86% identical to that in Cystobacter sp. SBCb004 known as a tubulysin-producing myxobacterium, and the organization of the clusters was identical except for the lack of a tubZ gene in the clusters in MEHO_002 and MEHO_004. The amino acid sequences of the proteins encoded by each gene were 88-97% similar to those encoded by SBCb004, and the domain compositions of the proteins were also identical.
Abstract
Tubulysins are a group of bioactive secondary metabolites from myxobacteria exhibiting strong anticancer activity against various cancer cell lines. In this study, we describe the identification of putative tubulysin biosynthetic gene clusters (tubA~tubF) in the genome sequences of two tubulysin-producing myxobacterial strains, Archangium gephyra MEHO_002 and MEHO_004. The inactivation of the putative tubulysin biosynthetic genes resulted in a tubulysin-production defect. The DNA sequences of the A. gephyra MEHO_002 and MEHO_004 tubulysin biosynthetic genes were 97% identical, and the amino acid sequences of the encoded proteins shared a similarity of 97−100%. The nucleotide sequences of the tubulysin biosynthetic gene clusters in MEHO_002 and MEHO_004 were 86% identical to that in Cystobacter sp. SBCb004 known as a tubulysin-producing myxobacterium, and the organization of the clusters was identical except for the lack of a tubZ gene in the clusters in MEHO_002 and MEHO_004. The amino acid sequences of the proteins encoded by each gene were 88-97% similar to those encoded by SBCb004, and the domain compositions of the proteins were also identical.
참고문헌 (25)
- Etienne-Manneville S, "From signaling pathways to microtubule dynamics : the key players", Curr. Opin. Cell Biol, 22, pp.104~111 (2010)
- Risinger AL, "Microtubule dynamics as a target in oncology", Cancer Treat. Rev, 35, pp.255~261 (2009)
- Sasse F, "Tubulysins, new cytostatic peptides from myxobacteria acting on microtubuli. Production, isolation, physico-chemical and biological properties", J. Antibiot, 53, pp.879~885 (2000)
- Khalil MW, "Mechanism of action of tubulysin, an antimitotic peptide from myxobacteria", ChemBioChem, 7, pp.678~683 (2006)
- Chai Y, "Discovery of 23 natural tubulysins from Angiococcus disciformis An d48 and Cystobacter SBCb004", Chem. Biol, 17, pp.296~309 (2010)
- Steinmetz H, "Isolation, crystal and solution structure determination, and biosynthesis of tubulysins - powerful inhibitors of tubulin polymerization from myxobacteria", Angew. Chem. Int. Ed, 43, pp.4888~4892 (2004)
- Dömling A, "Myxobacterial epothilones and tubulysins as promising anticancer agents", Mol. Divers, 9, pp.141~147 (2005)
- Kaur G, "Biological evaluation of tubulysin A : a potential anticancer and antiangiogenic natural product", Biochem. J, 396, pp.235~242 (2006)
- Murray BC, "Chemistry and biology of tubulysins : antimitotic tetrapeptides with activity against drug resistant cancers", Nat. Prod. Rep, 32, pp.654~662 (2015)
- Reddy JA, "Pre-clinical evaluation of EC1456, a folatetubulysin anti-cancer therapeutic", Sci. Rep, 8, pp.8943~ (2018)
- Szigetvari NM, "Phase I", II clinical trial of the targeted chemotherapeutic drug, folate-tubulysin, in dogs with naturallyoccurring invasive urothelial carcinoma, 2018, pp.9, 37042~37053
- Courter JR, "Structure-activity relationships of tubulysin analogues", Bioorg. Med. Chem. Lett, 30, pp.127241~ (2020)
- Sandmann A, "Identification and analysis of the core biosynthetic machinery of tubulysin, a potent cytotoxin with potential anticancer activity", Chem. Biol, 11, pp.1071~1079 (2004)
- 현혜숙, "Screening of Myxobacteria Carrying Tubulysin Biosynthetic Genes", 한국미생물·생명공학회지, 49(1), pp.32~38 (2021), 한국미생물·생명공학회[DOI]
- 신혜진, "Corallococcus와 Myxococcus 속 점액세균 균주들에 의한 항균 물질의 생산", 한국미생물·생명공학회지, 41(1), pp.44~51 (2013), 한국미생물·생명공학회[DOI]
- 이봉수, "분산 돌연변이 점액세균의 분리", 한국미생물·생명공학회지, 31(4), pp.342~347 (2003), 한국미생물·생명공학회
- Sambrook J, "Molecular Cloning: a Laboratory Manual" (1989), Cold Spring Harbor Laboratory Press
- Blin K, "antiSMASH 5.0: updates to the secondary metabolite genome mining pipeline", Nucleic Acids Res, 47, pp.W81~W87 (2019)
- Johnson M, "NCBI BLAST : a better web interface", Nucleic Acids Res, 36, pp.W5~W9 (2008)
- Marchler-Bauer A, "CDD : NCBI's conserved domain database", Nucleic Acids Res, 43, pp.D222~D226 (2015)
- Shimkets LJ, "Correlation of energy-dependent cell cohesion with social motility in Myxococcus xanthus", J. Bacteriol, 166, pp.837~841 (1986)
- Chai Y, "Heterologous expression and genetic engineering of the tubulysin biosynthetic gene cluster using Red", ET recombineering and inactivation mutagenesis, 2012, pp.19, 361~371
- Ullrich A, "Pretubulysin, a potent and chemically accessible tubulysin precursor from Angiococcus disciformis", Angew. Chem. Int. Ed. Engl, 48, pp.4422~4425 (2009)
- Selva E, "Antibiotics A21459 A and B, new inhibitors of bacterial protein synthesis. I. Taxonomy, isolation and characterization", J. Antibiot, 49, pp.145~149 (1996)
- Sasse F, "Argyrins, immunosuppressive cyclic peptides from myxobacteria. I. Production, isolation, physicochemical and biological properties", J. Antibiot, 55, pp.543~551 (2002)